Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest Pharmaceuticals

12 Jun, 2018, 12:52 BST Galmed's 600 mg Aramchol™ Achieved a Regulatory Approvable Endpoint Showing NASH Resolution Without Worsening of Fibrosis, in NASH Patients, in the Global Phase 2b ARREST 52-Week Study

- Statistically significant reduction in liver fat was demonstrated by Magnetic Resonance Spectroscopy (MRS) in patients completing 52...


12 Jun, 2018, 12:25 BST Grünenthal Initiates Pivotal Phase III Trials in Complex Regional Pain Syndrome

Grünenthal announced today that first patients have been enrolled in two trials of the company's pivotal phase III program investigating...


12 Jun, 2018, 10:23 BST Today, First International NASH Day: A First of its Kind Call to Action for Patients, Individuals at Risk, Medical Staff and Media

Today is a first-of-its-kind disease awareness event, the First International NASH Day, paving the way for a better care for millions of NASH...


12 Jun, 2018, 07:25 BST Targovax Hosts Conference Call 12 June 2018

Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing and commercializing immune activating...


12 Jun, 2018, 07:03 BST Nordic Nanovector Announces Betalutin® has been Granted Fast Track Designation in the US for Follicular Lymphoma

Nordic Nanovector ASA (OSE: NANO) announces that the US Food & Drug Administration (FDA) has granted Fast Track designation to Betalutin®...


11 Jun, 2018, 20:37 BST Endo Announces Master Settlement Agreement Allowing for Resolution of Known Testosterone Replacement Therapy Product Liability Claims and Entry of Significant Case Management Order

Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries Endo Pharmaceuticals Inc. and Auxilium Pharmaceuticals, LLC...


11 Jun, 2018, 18:51 BST Targovax Strengthens Focus on ONCOS Oncolytic Virus Development Program

Recent clinical data is driving increased interest in the industry for oncolytic viruses as an emerging class of cancer therapeutics Development...


11 Jun, 2018, 15:30 BST Pharmaleads Presents New Data Showing DENKIs, a New Class of Painkillers, to be Devoid of Abuse Potential and Opiate Side-Effects

Clinical and preclinical data demonstrating efficacy, safety and tolerability presented at the Annual International Conference on Opioids in...


11 Jun, 2018, 13:30 BST Insomnia Treatment Market to Gain Valuation Worth US$ 7.5 Bn by 2026 - Persistence Market Research

Innovations in Healthtech and Pharma to Redefine Treatment for Insomnia Technological innovations have revolutionized lifestyle, communication,...


11 Jun, 2018, 13:30 BST PharmaMar Signs a Commercialization and Distribution License Agreement for Aplidin® With Pint Pharma International

PharmaMar (MCE: PHM) has announced today the signing of a commercialization and distribution license agreement with Pint Pharma International,...


11 Jun, 2018, 13:30 BST Global Regenerative Medicine Market Expected to Reach $39,325 Million by 2023, Says Allied Market Research

According to a new report published by Allied Market Research, titled, Regenerative Medicine Market by Product Type, Material, and Application:...


11 Jun, 2018, 12:00 BST Norgine France With 100 Years of Expertise Celebrates New Manufacturing Investment

Norgine B.V. a European specialist pharmaceutical company announced today the visit of Olivier Marleix, Member of the French Assemblée Nationale...


11 Jun, 2018, 12:00 BST Replimune Appoints Dr. Hyam I. Levitsky to Board of Directors

Replimune Group Inc., a biotechnology company developing next generation oncolytic immunotherapies, announced today it has appointed Hyam I....


11 Jun, 2018, 09:25 BST AniCura schließt sich Mars Petcare an

AniCura, ein führender europäischer Anbieter in der qualitativ hochwertigen tierärztlichen Versorgung für Haustiere, begrüßt den zukünftigen...


11 Jun, 2018, 07:00 BST ELEVATE Study Aims to Improve Selection Criteria and Outcomes for Patients with Severe Emphysema Treated with the PneumRx™ Endobronchial Coil System

Recruitment Begins in 7 European Countries BTG plc (LSE: BTG), the global healthcare company, today announces the start of ELEVATE: A randomizEd...


11 Jun, 2018, 06:26 BST Nordic Nanovector to Present Preclinical Data Demonstrating Betalutin® Reverses Resistance to Anti-CD20 Treatment in NHL Cells

Nordic Nanovector ASA (OSE: NANO) announces that a poster reporting the ability of Betalutin® (177Lu-lilotomab satetraxetan) to reverse resistance...


11 Jun, 2018, 06:00 BST IO Biotech Appoints Kathleen Sereda Glaub as Member of Board of Directors

IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune modulating anti-cancer therapies, based on its proprietary T-win...


08 Jun, 2018, 15:30 BST Analysts Predict Big Year in Biotech M&A

FN Media Group Presents Microcapspeculators.com News Commentary An $11-billion burst of biotechnology bids in just four days in January fueled...


08 Jun, 2018, 14:45 BST Global Hereditary Angioedema Market Forecast 2018-2028 - Visiongain Report

C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor Antagonist, Kallikrein Inhibitor (Kalbitor), Cinryze, Berinert, Ruconest, Intravenous,...


07 Jun, 2018, 16:00 BST Ketamine Clinics of Los Angeles Makes History as the First Ketamine Clinic to Earn AAAASF Accreditation for Patient Safety

Ketamine Clinics of Los Angeles Raises the Bar for Safe IV Ketamine Infusion Therapy Ketamine Clinics of Los Angeles, the country's leading...


07 Jun, 2018, 14:30 BST Multiplex Assays Market Worth 3.35 Billion USD by 2023

According to a new market research report "Multiplex Assays Market by Product (Consumables, Instruments), Type (Nucleic Acid, Protein, Cell),...


07 Jun, 2018, 14:00 BST Data Shows Medical Cannabis Market Value is Set to Grow

FinancialBuzz.com News Commentary According to data compiled by Oristep Consulting, the global medical cannabis market was worth USD 12.67...


07 Jun, 2018, 09:00 BST VECT-HORUS Raises 3.5 M€ to Accelerate Its Development Programs

VECT-HORUS, a biotechnology company that designs and develops vectors facilitating targeting of therapeutic molecules and imaging agents,...


07 Jun, 2018, 07:24 BST Swiss WorldCargo Reaches 36 QEP Accredited Stations

Envirotainer, the global market leader in secure cold chain solutions for the pharmaceutical supply chain, announced today that Swiss WorldCargo...


07 Jun, 2018, 07:00 BST 4D pharma plc Enters Into Clinical Collaboration Agreement With MSD Investigating the Combination of KEYTRUDA® (pembrolizumab) and MRx0518 in Patients With Solid Tumours

4D pharma plc (AIM: DDDD) today announced an agreement with a subsidiary of MSD (tradename of Merck & Co., Inc., Kenilworth, N.J., USA) to...